Mark Polhemus is an Infectious Disease physician affiliated with Walter Reed Army Institute of Research. OpenAlex indexes 65 publications with 2,749 citations (h-index 28); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
715 Dr Martin Luther King Jr Ave NE Ste 201
Albuquerque, NM 871023667
Telephone
505-727-3020Provider last certified this registry record 9 Oct 2024.
Clinical trials
- TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B Adjuvant
Sponsor: U.S. Army Medical Research and Development Command
- Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis
Sponsor: State University of New York - Upstate Medical University
- Zinc Supplementation to Reduce Diarrhea Rates in Adults in Western Kenya.
Sponsor: United States Army Research Institute of Environmental Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20235 payments
- Philips Electronics North America CorporationProgram year20232 payments
- Merck Sharp & Dohme LLCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Penicillins with extended spectrum30%Amoxicillin-Clavulanate Potass67%Amoxicillin33%Part D<11 patientsTetracycline-class Drug25.3%Doxycycline Hyclate100%Part D≥22 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Phase 1, Open-Label Assessment of a Dengue Virus-1 Live Virus Human Challenge Strain
The Journal of Infectious Diseases
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Walter Carr, MD
Walter Reed Army Institute of Research
Paul Robben, MD
Walter Reed Army Institute of Research
Adrian Kress, MD
Walter Reed Army Institute of Research
Kristen Barner, MD
Walter Reed Army Institute of Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”